NCT01882322View on ClinicalTrials.gov

A Study to Evaluate the Effect of Advagraf Conversion From Prograf in Liver Transplant Subjects

PHASE4CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

January 30, 2013

Primary Completion Date

January 3, 2017

Study Completion Date

January 3, 2017

Conditions
de Novo Liver Transplant Subjects
Interventions
DRUG

Prograf

oral

DRUG

Advagraf

oral

Trial Locations (1)

Unknown

Seoul

All Listed Sponsors
lead

Astellas Pharma Korea, Inc.

INDUSTRY

NCT01882322 - A Study to Evaluate the Effect of Advagraf Conversion From Prograf in Liver Transplant Subjects | Biotech Hunter | Biotech Hunter